glp-1 announcement today CMS has announced important updates to Medicare coverage of medications for 2027. Instead of transitioning to the BALANCE Model, Medicare coverage for GLP-1 medications used for weight management will continue through GLP-1 Pipeline Update: August 2025
Description
SNP: single nucleotide polymorphisms
"I just felt awful
[15] In Summary, Long-Term Changes in Grocery Spending After Starting GLP-1 Drugs Households experience an initial decline of approximately 6% within the first 6 months
Even at low doses, muscle loss, nutritional deficiencies, and rebound weight gain remain possible if not paired with supportive strategies like: In short, microdosing Ozempic is an emerging and somewhat experimental approach
If you are curious about which path is right for you, we invite you to take the free assessment quiz
